Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Adagio Therapeutics (the “Company”) on Form 10-Q for the period ended June 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
Date: September 20, 2021 |
| By: | /s/ Tillman U. Gerngross, Ph.D. |
|
|
| Tillman U. Gerngross, Ph.D. |
|
|
| Chief Executive Officer |
|
|
| (Principal Executive Officer) |